Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Irbesartan and Amlodipine in Essential Hypertension
NCT04488978Phase 2Completed
- Sponsor
- Handok
- Start
- May 2020
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irbesartan, amlodipine in essential hypertension, sponsored by Handok. Started May 2020; status: completed.
02
Drugs
irbesartanamlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT04488978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04488978.